CAPTRUST Financial Advisors
DNA icon

CAPTRUST Financial Advisors’s Ginkgo Bioworks DNA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-455
Closed -$6.08K – 2314
2024
Q2 		$6.08K Buy
455
+75
+20% +$2.24K ﹤0.01% 2194
2024
Q1 		$17.6K Sell
380
-1,532
-80% -$79.3K ﹤0.01% 2117
2023
Q4 		$129K Sell
1,912
-296
-13% -$18.1K ﹤0.01% 2493
2023
Q3 		$160K Buy
2,208
+196
+10% +$15.7K ﹤0.01% 2351
2023
Q2 		$150K Buy
2,012
+830
+70% +$49.1K ﹤0.01% 2329
2023
Q1 		$62.9K Buy
+1,182
New +$74.9K ﹤0.01% 2199
2022
Q4 		– Sell
-972
Closed -$121K – 2094
2022
Q3 		$121K Buy
972
+516
+113% +$61.5K ﹤0.01% 1917
2022
Q2 		$43K Buy
456
+48
+12% +$5.85K ﹤0.01% 2863
2022
Q1 		$66K Buy
408
+283
+226% +$55.1K ﹤0.01% 2584
2021
Q4 		$42K Sell
125
-3
-2% -$1.43K ﹤0.01% 2789
2021
Q3 		$59K Buy
+128
New +$62.3K ﹤0.01% 2465

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return